Literature DB >> 1417313

[Comparison of therapeutic effects of antibiotics of the tetracycline group in the treatment of anthrax caused by a strain inheriting tet-gene of plasmid pBC16].

A P Pomerantsev, N A Shishkova, L I Marinin.   

Abstract

In vivo and in vitro efficacy of tetracyclines was studied with respect to anthracic infection induced by a tetracycline-resistant resistant strain containing plasmid pBC16. The plasmid-containing strain was resistant to tetracycline, doxycycline and minocycline, the MICs exceeding those for the initial strain 500, 640 and 80 times, respectively. There was no therapeutic effect of tetracycline and doxycycline in the treatment and urgent prophylaxis of anthracic infection caused by the tetracycline-resistant strain of Bacillus anthracis. High therapeutic efficacy of minocycline in the average therapeutic concentrations was shown irrespective of the contaminating doses and strains. Minocycline was recommended for treatment and urgent prophylaxis of anthracic infection caused by tetracycline-resistant B. anthracis strains.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1417313

Source DB:  PubMed          Journal:  Antibiot Khimioter        ISSN: 0235-2990


  13 in total

1.  Antibiotic susceptibilities of 96 isolates of Bacillus anthracis isolated in France between 1994 and 2000.

Authors:  Jean-Didier Cavallo; Francoise Ramisse; Monique Girardet; Josée Vaissaire; Michelle Mock; Eric Hernandez
Journal:  Antimicrob Agents Chemother       Date:  2002-07       Impact factor: 5.191

2.  Biochemical characterization of beta-lactamases Bla1 and Bla2 from Bacillus anthracis.

Authors:  Isabel C Materon; Anne Marie Queenan; Theresa M Koehler; Karen Bush; Timothy Palzkill
Journal:  Antimicrob Agents Chemother       Date:  2003-06       Impact factor: 5.191

3.  A rapid antimicrobial susceptibility test for Bacillus anthracis.

Authors:  Linda M Weigel; David Sue; Pierre A Michel; Brandon Kitchel; Segaran P Pillai
Journal:  Antimicrob Agents Chemother       Date:  2010-05-03       Impact factor: 5.191

4.  Optical Screening for Rapid Antimicrobial Susceptibility Testing and for Observation of Phenotypic Diversity among Strains of the Genetically Clonal Species Bacillus anthracis.

Authors:  Heather P McLaughlin; Amy S Gargis; Pierre Michel; David Sue; Linda M Weigel
Journal:  J Clin Microbiol       Date:  2017-01-04       Impact factor: 5.948

5.  Rapid identification of genetic modifications in Bacillus anthracis using whole genome draft sequences generated by 454 pyrosequencing.

Authors:  Peter E Chen; Kristin M Willner; Amy Butani; Shakia Dorsey; Matroner George; Andrew Stewart; Shannon M Lentz; Christopher E Cook; Arya Akmal; Lance B Price; Paul S Keim; Alfred Mateczun; Trupti N Brahmbhatt; Kimberly A Bishop-Lilly; Michael E Zwick; Timothy D Read; Shanmuga Sozhamannan
Journal:  PLoS One       Date:  2010-08-25       Impact factor: 3.240

Review 6.  Anti-toxin antibodies in prophylaxis and treatment of inhalation anthrax.

Authors:  Anette Schneemann; Marianne Manchester
Journal:  Future Microbiol       Date:  2009-02       Impact factor: 3.165

7.  Delineation of the Residues of Bacillus anthracis Zinc Uptake Regulator Protein Directly Involved in Its Interaction with Cognate DNA.

Authors:  Divya Kandari; Hemant Joshi; Neetu Tanwar; Manoj Munde; Rakesh Bhatnagar
Journal:  Biol Trace Elem Res       Date:  2020-10-14       Impact factor: 3.738

8.  In vitro selection and characterization of Bacillus anthracis mutants with high-level resistance to ciprofloxacin.

Authors:  Lance B Price; Amy Vogler; Talima Pearson; Joseph D Busch; James M Schupp; Paul Keim
Journal:  Antimicrob Agents Chemother       Date:  2003-07       Impact factor: 5.191

Review 9.  Alternative pre-approved and novel therapies for the treatment of anthrax.

Authors:  Breanne M Head; Ethan Rubinstein; Adrienne F A Meyers
Journal:  BMC Infect Dis       Date:  2016-11-03       Impact factor: 3.090

10.  Evaluation of the European Committee on Antimicrobial Susceptibility Testing Guidelines for Rapid Antimicrobial Susceptibility Testing of Bacillus anthracis-, Yersinia pestis- and Francisella tularensis-Positive Blood Cultures.

Authors:  Ohad Shifman; Tamar Aminov; Moshe Aftalion; David Gur; Hila Cohen; Elad Bar-David; Ofer Cohen; Emanuelle Mamroud; Haim Levy; Ronit Aloni-Grinstein; Ida Steinberger-Levy; Shahar Rotem
Journal:  Microorganisms       Date:  2021-05-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.